1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e72.
2. Petrea RE, Biser AS, Sashadri S, et al. Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study. Stroke. 2009;40:4.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587.
4. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2944.
5. Katzan IL, Cebul RD, Husak SH, et al. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625.
6. Vemmos KN, Spengos K, Tsivgoulis G, et al. Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens. 2004;18:253–259.
7. Aslanyan S, Fazekas F, Weir CJ, et al, GAIN International Steering Committee and Investigators. Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome. Stroke. 2004;35:e153–e155.
8. Castillo J, Leira R, Garcia MM, et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35:520–526.
9. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 198;29:1504–1509.
10. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association, Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research and Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38;1655–1711.
11. Bruno A, Levine SR, Frankel MR, et al, NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669–674.
12. Brunkhorst FM. Intensive insulin
therapy in patients with severe sepsis and septic shock is associated with an increased rate of hypoglycemia—results from a multicenter randomized controlled study (VISEP). Infection.
13. Gray CS, Hildreth AJ, Sandercock PA, et al. GIST Trialists Collaboration. Glucose–potassium–insulin infusions in the management of post-stroke hyperglycemia: the UK Glucose Insulin
in Stroke Trial (GIST-UK). Lancet Neurol.
14. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology. 2000;55(11):1649–1655.
15. Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, eds. Stroke: Pathophysiology, Diagnosis, and Management; 4th ed. Churchill Livingston. 2004.
16. Shafquat S, Kvedar JC, Guanci MM, et al. Role for telemedicine in acute stroke: feasibility and reliability of remote administration of the NIH stroke scale. Stroke. 1999;30;2141–2145.
17. Wiborg A, Widder B. Teleneurology to improve stroke care in rural areas: the Telemedicine in Stroke in Swabia (TESS) project. Stroke. 2003;34;2951–2956.
18. Hemmen TM, Meyer BC, McClean TL et al. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J Stroke Cerebrovasc Dis. 2008;17(1):23–25.
19. Batmanian JJ, Lam M, Matthews C, et al. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department. Med J Aust. 2007;187(10):567–570.
20. Wahlgren N, Davalos A, Ford GA, et al. Thrombolysis with alteplase
for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet.
21. DeKeyser JD, Gdovinova Z, Uyttenboogaart M, et al. Intravenous alteplase
for stroke: beyond the guidelines and in particular clinical situations. Stroke.
22. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis of stroke patients in ≥ 80 versus < 80 years of age—a systematic review across cohort studies. Age Ageing. 2006;35:572–580.
23. Lopez-Yunez AM, Runo A, Williams LS, et al. Protocol violations in community based rTPA stroke treatment are associated with symptomatic intracranial hemorrhage. Stroke. 2001;32;12–16.
24. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase
3 to 4.5 hours after acute ischemic stroke. N Engl J Med.
25. del Zoppo GJ, Saver JL, Jauch EC
, et al, on behalf of the American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke.
26. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial rt-PA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598–2605.
27. Furlan A, Higashida R, Wechsle L, e al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA. 1999;282;2003–2011.
28. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005;36:1432–1438.
29. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40(8):2761–2768.